Astec LifeSciences Limited has announced the successful completion of interest payment on its Non-Convertible Debentures (NCDs), demonstrating its commitment to timely debt servicing obligations. The company informed both BSE and NSE about this development through a regulatory filing dated March 27, 2026.

Interest Payment Details

The company made a substantial interest payment as part of its debt obligations. The payment details showcase the company's financial discipline and adherence to scheduled commitments.

Regulatory Compliance

The intimation was made under Regulations 30 and 57 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This filing also complies with the Master Circular for issue and listing of Non-Convertible Securities, Securitised Debt Instruments, Security Receipts, Municipal Debt Securities and Commercial Paper dated October 15, 2025.

Payment Status Confirmation

The company confirmed that the interest payment was made successfully without any delays or complications. Key status indicators include:

Corporate Communication

The regulatory filing was signed by Tejashree Pradhan, Company Secretary & Compliance Officer (FCS 7167), and was digitally authenticated on March 27, 2026. The communication was addressed to both BSE Limited (Scrip Code: 533138) and National Stock Exchange of India Limited (Symbol: ASTEC), ensuring comprehensive market disclosure.

This timely interest payment reflects the company's strong financial management and commitment to honoring its debt obligations as scheduled, providing confidence to debenture holders and the broader investment community.

Astec LifeSciences Limited has announced the reaffirmation of its credit ratings by ICRA Limited across multiple debt facilities. The rating agency communicated its decisions through letters dated March 24, 2026, covering facilities totaling Rs.1,068 Crore. The company has informed both BSE Limited and National Stock Exchange of India Limited about these rating actions as per regulatory compliance requirements under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Credit Rating Details

ICRA Limited has reaffirmed ratings across five different categories of debt instruments and facilities. The rating actions encompass both long-term and short-term facilities, maintaining the company's existing credit profile.

Rating Significance

The 'ICRA AA-' rating indicates high credit quality with adequate degree of safety regarding timely servicing of financial obligations. However, the negative outlook on long-term facilities suggests potential for downward rating movement in the medium term. The 'ICRA A1+' rating for short-term facilities indicates very strong degree of safety regarding timely payment of financial obligations.

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulations 30 and 51 of SEBI Listing Regulations. The rating letters have been shared with stock exchanges, and the information will be made available on the company's website at www.godrejastec.com as per regulatory requirements.

Key Rating Conditions

ICRA Limited has specified several conditions accompanying the rating reaffirmation:

• Ratings are subject to surveillance within one year from the communication date
• Any changes in terms or size of rated instruments require rating review
• The company must inform ICRA about any defaults or delays in debt servicing
• Commercial Paper ratings require revalidation if instruments are not issued within three months

The rating agency reserves the right to review and revise ratings based on new information or changing circumstances that could impact the company's credit profile.